Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2151
https://www.valueinhealthjournal.com/article/S1098-3015(16)33517-3/fulltext
Title :
Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33517-3&doi=10.1016/j.jval.2016.09.2151
First page :
A722
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2039